Reply  by Eslami, Mohammad H.
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 1 Letters to the Editor 259and IC. A multivariate analysis still confirmed that IR had a higher
mortality rate, but the odds ratios for renal failure, emergent, and
urgent procedures were far higher than the odds ratio for specialty. In
addition, there is no stratification for type of intervention, such as
thrombolysis, nor for clinical indication for the revascularization
(claudication vs critical limb ischemia). Given the higher prevalence of
urgent and emergent cases and renal failure among patients treated by
IR physicians, it is very likely that there was also a higher utilization of
thrombolysis and treatment of patients with critical limb ischemia,
both of which are likely to lead to higher complication rates.
I believe the above comments raise significant questions re-
garding the validity of the conclusions regarding interspecialty
differences in quality in the endovascular treatment of peripheral
arterial disease.
David Sacks, MD
The Reading Hospital and Medical Center
Interventional Radiology
West Reading, Pa
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Reply
This is in response to the letter, Regarding “Peripheral arterial
interventions: Trends in market share and outcomes by specialty,
1998-2005,”1 in which the authors expressed concerns about our
recent publication in the Journal of Vascular Surgery.2 I appreciate
their careful review of our work, and I would like to address several
points raised by the authors.
In the text of our discussion, we acknowledge that these data
were only limited to the National Inpatient Sample database.1 We
noted that, “An unknown portion of procedures that were per-
formed on an outpatient basis is therefore missing from this
database and that may change the market share trends.”1 The
current practice of outpatient peripheral interventions is, however,
relatively new3; and as we noted, the most recent guidelines of the
Society of Interventional Radiology in 2003 still suggest in-hospital
observation.4 We therefore are confident that most of the procedures
were captured by this database and in our analysis. Additionally,
there is no way of concretely addressing whether one specialty
would do more outpatient procedures than others that might skew
the market share trends observed here.
The authors compare our results for the year 2002 with the
publication by Dr Levin5 and note the lack of congruence between
the two publications for that year. Although an unknown compo-
nent of these differences stems from the inclusion of outpatient
procedures, which in 2002 was not very common given the 2003
Guidelines,4 another difference stems from the exclusion of non-
Medicare patients in that publication, where the Medicare database
was used.5 In our article, we noted that about 31% of patients had
providers other than Medicare.1
The authors claim, “Patients with lower extremity arteriography
were included for analysis.” This is incorrect. Our analysis was per-
formed only on the patients who had interventions with International
Classification of Diseases, 9th Clinical Modification codes 39.50,
39.90, 00.55.1 I respectfully point to paragraph 2 of the Methods.1
The authors state, “Eslami states that for IC only 5% of
interventions are performed at the same time as the diagnostic
arteriogram.” To clarify, this is a finding by Axlerod et al.6The authors suggest, “It is possible there was systemic under-
reporting of iatrogenic arterial injuries by vascular surgeons. For
example, a coder may not note a complication if a surgeon con-
verted a percutaneous to an open femoral access due to problems
with the access.” Admittedly, it is possible that a case that is initially
percutaneous may need to be converted to open by a vascular
surgeon with capability to do open access due to access complica-
tions. But it is inflammatory and inaccurate to call that a “systemic
under-reporting” that may affect this analysis. Having that said, I
would like to suggest to the authors then that, given that the vascular
surgeons are the only specialty group who can deal with iatrogenic
injuries in addition to having endovascular expertise, maybe they
should be the only group performing these interventions.
As for as the identification of the specialties, we acknowledge
that the 20% of providers who were identified as “others” may
include members of all three specialties.1 It is illogical to suggest
that one group was more represented in the “other” group. Here,
the authors’ claim, inaccurately, that, “If an IR [interventional
radiologist] performed EVAR that physician would be labeled as
‘other’ because EVAR is considered a procedure limited to vascular
surgeons.” Please refer to the third paragraph of Methods.1 If an
IR specialist does only EVARs and no other interventions, we
would have admittedly captured that specialist in the vascular surgery
(VS) group. This would be a very unusual set of circumstances and
would account for very small number, if any, of IR providers. Addi-
tionally, Levin et al7 recently published their results on the market
trends for EVAR using the Medicare database from 2001 to 2006.
They noted an ever-increasing number of vascular surgeons perform-
ing EVARs (76% market share for VS vs 11% for IR and 7% IC).7
I concur with the authors that some of clinical information
about the patients is missing in the National Inpatient Sample
database, and this is why we went to great lengths in the discussion
to address this likely unmeasured selection bias from administrative
datasets.1 But multivariate logistic regression analysis adjusts for all
the confounding variables and allows for evaluation of odds ratio
independent of the confounding variables.
Thank you again for carefully reviewing our work, on
behalf of the authors.
Mohammad H. Eslami, MD
Division of Vascular Surgery
University of Massachusetts Medical School
Worcester, Mass
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